pocketful logo
Aarti Drugs Ltd logo

Aarti Drugs Ltd

NSE: AARTIDRUGS BSE: 524348

₹367

(-0.65%)

Wed, 11 Mar 2026, 04:38 am

Aarti Drugs Enterprise Value (EV)

Particulars20052006200720082009201020112012201320142015201620172018201920202021202220232024
Price to earnings ratio9.897.114.472.794.326.525.713.835.2520.4316.0116.7814.5216.838.3323.0919.3718.8123.2718.44
Price to book ratio1.180.730.550.360.820.950.700.841.275.123.083.432.622.781.817.093.832.623.112.27
Price to sales ratio0.520.340.200.120.250.310.190.210.331.440.971.150.960.970.653.011.601.151.581.30
Price to cash flow ratio05.464.141.362.9843.7810.123.735.0423.8912.199.8933.3714.455.4047.1176.1731.6912.0813.89
Enterprise value3.28B3.06B2.89B2.43B3.06B4.17B4.16B4.91B6.93B20.23B15.79B18.48B17.37B20.12B15.6B68.16B44.93B37.28B45.44B37.09B
Enterprise value to EBITDA ratio8.787.356.413.763.685.965.584.074.7311.848.949.518.529.445.8215.3513.3311.8314.2012.94
Debt to equity ratio2.161.991.951.561.291.641.691.541.511.451.351.201.200.930.600.380.520.510.440.45
Return on equity %16.3014.6412.9813.5920.7315.3512.7223.5626.5227.6420.6521.6019.2417.9723.6535.8121.0314.9213.8612.69

Aarti Drugs Ltd Enterprise Value

The Aarti Drugs Ltd Enterprise Value is a key financial metric used by investors to evaluate Aarti Drugs Ltd's valuation, profitability, and overall financial performance. Tracking the Aarti Drugs Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Aarti Drugs Ltd (NSE: AARTIDRUGS, BSE: 524348) is currently trading at ₹367, with a market capitalization of ₹33.5B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Aarti Drugs Ltd Enterprise Value is essential for fundamental analysis.

Aarti Drugs Ltd Enterprise Value Current Value

The current Aarti Drugs Ltd Enterprise Value stands at 37.09B.

The Aarti Drugs Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Aarti Drugs Ltd Enterprise Value Historical Trend

The Aarti Drugs Ltd Enterprise Value has shown the following historical trend:

  • 2024: 37.09B
  • 2023: 45.44B
  • 2022: 37.28B
  • 2021: 44.93B
  • 2020: 68.16B

The decline in Aarti Drugs Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.

What Aarti Drugs Ltd Enterprise Value Indicates for Investors

The Aarti Drugs Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Aarti Drugs Ltd.

Aarti Drugs Ltd Enterprise Value Analysis Summary

The Aarti Drugs Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Aarti Drugs Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Aarti Drugs Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800